Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.14 HKD
1.77 B HKD
12.75 B HKD
285.21 M
About PHARMARON BEIJING
Sector
CEO
Bo Liang Lou
Website
Headquarters
Beijing
Founded
2004
ISIN
CNE100003PG4
FIGI
BBG00QRW0H13
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services. The company was founded by Bo Liang Lou, Xiao Qiang Lou and Bei Zheng on July 1, 2004 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 3759 is 14.02 HKD — it has increased by 0.43% in the past 24 hours. Watch PHARMARON BEIJING CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange PHARMARON BEIJING CO LTD stocks are traded under the ticker 3759.
3759 stock has risen by 3.39% compared to the previous week, the month change is a 7.85% rise, over the last year PHARMARON BEIJING CO LTD has showed a −5.27% decrease.
We've gathered analysts' opinions on PHARMARON BEIJING CO LTD future price: according to them, 3759 price has a max estimate of 24.20 HKD and a min estimate of 8.00 HKD. Watch 3759 chart and read a more detailed PHARMARON BEIJING CO LTD stock forecast: see what analysts think of PHARMARON BEIJING CO LTD and suggest that you do with its stocks.
3759 reached its all-time high on Jul 2, 2021 with the price of 94.22 HKD, and its all-time low was 7.98 HKD and was reached on Jul 9, 2024. View more price dynamics on 3759 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
3759 stock is 2.61% volatile and has beta coefficient of 2.09. Track PHARMARON BEIJING CO LTD stock price on the chart and check out the list of the most volatile stocks — is PHARMARON BEIJING CO LTD there?
Today PHARMARON BEIJING CO LTD has the market capitalization of 25.13 B, it has decreased by −1.49% over the last week.
Yes, you can track PHARMARON BEIJING CO LTD financials in yearly and quarterly reports right on TradingView.
PHARMARON BEIJING CO LTD is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
3759 earnings for the last quarter are 0.19 HKD per share, whereas the estimation was 0.25 HKD resulting in a −23.19% surprise. The estimated earnings for the next quarter are 0.30 HKD per share. See more details about PHARMARON BEIJING CO LTD earnings.
PHARMARON BEIJING CO LTD revenue for the last quarter amounts to 3.51 B HKD, despite the estimated figure of 3.70 B HKD. In the next quarter, revenue is expected to reach 3.64 B HKD.
3759 net income for the last quarter is 335.58 M HKD, while the quarter before that showed 952.99 M HKD of net income which accounts for −64.79% change. Track more PHARMARON BEIJING CO LTD financial stats to get the full picture.
Yes, 3759 dividends are paid annually. The last dividend per share was 0.22 HKD. As of today, Dividend Yield (TTM)% is 1.57%. Tracking PHARMARON BEIJING CO LTD dividends might help you take more informed decisions.
PHARMARON BEIJING CO LTD dividend yield was 1.39% in 2023, and payout ratio reached 22.03%. The year before the numbers were 0.61% and 24.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 20.30 K employees. See our rating of the largest employees — is PHARMARON BEIJING CO LTD on this list?
Like other stocks, 3759 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARON BEIJING CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARON BEIJING CO LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARON BEIJING CO LTD stock shows the neutral signal. See more of PHARMARON BEIJING CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.